• News
• Trial Summary
  • Overview
  • Trial Schema
  • Eligibility Criteria
• Scientific Summary
• Participating Institutions
• Governance
  • Sponsor and Co-ordination
  • The Governing Committees
  • Regulatory and Ethical Review
• Community Involvement
• Publications and Presentations
• FAQ’s
• Useful Links
• Contact Us
• Members Area

home > trial summary > eligibility criteria

Eligibility Criteria

Inclusion Criteria

1. Children should have an adult carer in the household who if HIV positive is receiving Anti-HIV therapy if needed.
2. Parents or guardians, and children where appropriate must be willing and able to give informed consent.
3. Children must have a documented diagnosis of HIV infection.
4. Age 6 months to 12 years (upto 17 years for children from DART households).
5. Previously untreated with anti-HIV drugs (other than for the prevention of mother to child transmission).
6. Children must fulfil World Health Organisation criteria for starting treatment.

Exclusion criteria

1. Cannot, or unlikely to attend regularly.
2. Likelihood of poor adherence.
3. Presence of acute infection.
4. Receiving medication that cannot be taken in combination with anti-HIV drugs.
5. Laboratory abnormalities which prevent anti-HIV drugs being taken.
6. Girls: Pregnancy or breast-feeding.